13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-17, with 28 holding rows worth $207,762,000.
- Accession
- 0000930413-15-000640
- Filer
- CIK 1281446
- Filed
- 2015-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 28 entries on the cover page, a total value of $207,762,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $207,762,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CONNECTURE INC COM | 20786J106 | Stock | 5,502,965 | $49,582,000 | thousands by filing date | |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 998,066 | $23,953,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 2,619,853 | $14,514,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 1,963,778 | $12,509,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 1,185,632 | $11,038,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 625,000 | $10,556,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 650,000 | $9,939,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 2,485,576 | $8,883,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 1,126,835 | $8,316,000 | thousands by filing date | |
| ARADIGM CORP | 038505400 | COM NO PAR NEW | 1,002,962 | $7,623,000 | thousands by filing date | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 250,000 | $6,808,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,170,000 | $6,597,000 | thousands by filing date | |
| SYNTHETIC BIOLOGICS INC | 87164U102 | COM | 3,998,941 | $5,839,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 554,426 | $5,356,000 | thousands by filing date | |
| TENAX THERAPEUTICS INC | 88032L100 | COM | 1,108,593 | $4,257,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 920,300 | $3,654,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 110,000 | $3,307,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 2,233,711 | $3,217,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 170,816 | $2,967,000 | thousands by filing date | |
| VICAL INC | 925602104 | COM | 2,117,941 | $2,224,000 | thousands by filing date | |
| Onconova Therapeutics | 68232V108 | Common | 553,079 | $1,820,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 50,000 | $1,152,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 46,200 | $1,032,000 | thousands by filing date | put |
| MEI PHARMA INC | 55279B202 | COM NEW | 157,661 | $673,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 151,611 | $656,000 | thousands by filing date | |
| ZOGENIX INC | 98978L105 | COM | 367,502 | $503,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 250,000 | $395,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 213,215 | $392,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-15-000640 | this filing | 2015-02-17 | acceptance time not in the bulk data set |